Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

Autor: Lahdensuo, Kanerva, Erickson, Andrew, Saarinen, Irena, Seikkula, Heikki, Lundin, Johan, Lundin, Mikael, Nordling, Stig, Bützow, Anna, Vasarainen, Hanna, Boström, Peter J, Taimen, Pekka, Rannikko, Antti, Mirtti, Tuomas

Publikováno v: In Modern Pathology December 2016 29(12):1565-1574

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.

Autor: Björk JK; Institute of Biomedicine, University of Turku, Turku, Finland., Ahonen I; Department of Mathematics and Statistics, University of Turku, Turku, Finland., Mirtti T; Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.; Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland., Erickson A; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.; Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland., Rannikko A; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Bützow A; Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland., Nordling S; Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland., Lundin J; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland., Lundin M; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland., Sistonen L; Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.; Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland., Nees M; Institute of Biomedicine, University of Turku, Turku, Finland., Åkerfelt M; Institute of Biomedicine, University of Turku, Turku, Finland.

Publikováno v: Oncotarget [Oncotarget] 2018 Jul 27; Vol. 9 (58), pp. 31200-31213. Date of Electronic Publication: 2018 Jul 27 (Print Publication: 2018).